To identify patients at higher risk of DP a number of independent prognostic factors such as LDT, soluble CD23, β2-m and serum thymidine kinase have been proposed in patients with early CLL (Molica, 2001). This evidence concerns the gene B2M and B-cell chronic lymphocytic leukemia.